1. Home
  2. ACCO vs EOLS Comparison

ACCO vs EOLS Comparison

Compare ACCO & EOLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACCO
  • EOLS
  • Stock Information
  • Founded
  • ACCO 1893
  • EOLS 2012
  • Country
  • ACCO United States
  • EOLS United States
  • Employees
  • ACCO N/A
  • EOLS N/A
  • Industry
  • ACCO Publishing
  • EOLS Biotechnology: Pharmaceutical Preparations
  • Sector
  • ACCO Consumer Discretionary
  • EOLS Health Care
  • Exchange
  • ACCO Nasdaq
  • EOLS Nasdaq
  • Market Cap
  • ACCO 356.9M
  • EOLS 406.9M
  • IPO Year
  • ACCO N/A
  • EOLS 2018
  • Fundamental
  • Price
  • ACCO $4.13
  • EOLS $6.50
  • Analyst Decision
  • ACCO Buy
  • EOLS Strong Buy
  • Analyst Count
  • ACCO 1
  • EOLS 4
  • Target Price
  • ACCO $6.00
  • EOLS $21.25
  • AVG Volume (30 Days)
  • ACCO 590.5K
  • EOLS 1.0M
  • Earning Date
  • ACCO 10-30-2025
  • EOLS 11-05-2025
  • Dividend Yield
  • ACCO 7.26%
  • EOLS N/A
  • EPS Growth
  • ACCO N/A
  • EOLS N/A
  • EPS
  • ACCO 0.49
  • EOLS N/A
  • Revenue
  • ACCO $1,581,200,000.00
  • EOLS $277,941,000.00
  • Revenue This Year
  • ACCO N/A
  • EOLS $13.68
  • Revenue Next Year
  • ACCO $2.11
  • EOLS $27.96
  • P/E Ratio
  • ACCO $8.43
  • EOLS N/A
  • Revenue Growth
  • ACCO N/A
  • EOLS 17.15
  • 52 Week Low
  • ACCO $3.32
  • EOLS $5.71
  • 52 Week High
  • ACCO $6.44
  • EOLS $17.82
  • Technical
  • Relative Strength Index (RSI)
  • ACCO 57.67
  • EOLS 44.82
  • Support Level
  • ACCO $4.03
  • EOLS $6.08
  • Resistance Level
  • ACCO $4.10
  • EOLS $6.36
  • Average True Range (ATR)
  • ACCO 0.11
  • EOLS 0.22
  • MACD
  • ACCO -0.01
  • EOLS 0.04
  • Stochastic Oscillator
  • ACCO 53.45
  • EOLS 71.96

About ACCO Acco Brands Corporation

ACCO Brands Corp designs, manufactures, and markets consumer and business products. It operates through two segments: ACCO Brands Americas, and ACCO Brands International. The company offers school notebooks, janitorial supplies, and whiteboards; storage and organization products, sheet protectors, and indexes, and punching products; computer accessories and others used in schools, homes, and businesses. The company markets and sells its products through various channels, including mass retailers; e-tailers; discount, and variety chains; and warehouse clubs. It generates maximum profit from ACCO Brands America segment.

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company with a customer-centric approach to delivering breakthrough products in the self-pay aesthetic market. The company's first commercial product is Jeuveau, a proprietary 900 kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Its primary market is the cash-pay aesthetic market, which includes medical products purchased by physicians and other customers that are then sold to consumers or used in procedures for aesthetic indications. It generates product revenue from the sale of Jeuveau in the United States and Europe, and service revenue from distribution partners in Canada.

Share on Social Networks: